Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selenium therapy of myotonic dystrophy.

G Orndahl, A Rindby, E Selin

    Acta Medica Scandinavica
    |January 1, 1983
    PubMed
    Summary

    Selenium and vitamin E supplementation improved a patient with myotonic dystrophy (MD). The treatment led to increased muscle strength and better electromyographic findings, marking a potential breakthrough in MD management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Microdiffraction studies of bone tissues using synchrotron radiation.

    Biomaterials·1998
    Same author

    The use of a scanning X-ray microprobe for simultaneous XRF/XRD studies of fly-ash particles.

    Journal of synchrotron radiation·1997
    Same author

    Otoneurologic and audiologic findings in fibromyalgia.

    Scandinavian journal of rehabilitation medicine·1996
    Same author

    Cerebral dysfunction in fibromyalgia: evidence from regional cerebral blood flow measurements, otoneurological tests and cerebrospinal fluid analysis.

    Acta psychiatrica Scandinavica·1995
    Same author

    Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study.

    Journal of internal medicine·1994
    Same author

    Zinc therapy in children with cystic fibrosis.

    Beitrage zur Infusionstherapie = Contributions to infusion therapy·1991

    Area of Science:

    • Biochemistry
    • Neurology
    • Clinical Medicine

    Background:

    • Myotonic dystrophy (MD) is a progressive genetic disorder affecting muscle function.
    • Current treatment options for MD are limited, focusing primarily on symptom management.
    • The role of micronutrients in MD pathogenesis and treatment is an area of ongoing research.

    Observation:

    • A single patient diagnosed with myotonic dystrophy was administered a two-year course of selenium and vitamin E.
    • Serum selenium levels and other clinical markers were monitored throughout the treatment period.
    • The study meticulously documented the patient's subjective and objective responses to the supplementation.

    Findings:

    • The patient exhibited significant subjective and objective clinical improvement.
    • A notable increase in muscular strength was observed.
    • Pathological electromyographic findings showed regression, indicating improved neuromuscular function.

    Implications:

    • This case report presents the first documented instance of successful therapeutic intervention for myotonic dystrophy using selenium and vitamin E.
    • The findings suggest a potential novel therapeutic strategy for managing myotonic dystrophy.
    • Further research, including larger clinical trials, is warranted to validate these preliminary results and explore the underlying mechanisms.

    Related Experiment Videos